These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SELDI-TOF-MS of saliva: methodology and pre-treatment effects. Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 15; 847(1):45-53. PubMed ID: 17070117 [Abstract] [Full Text] [Related]
4. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis. Papale M, Pedicillo MC, Di Paolo S, Thatcher BJ, Lo Muzio L, Bufo P, Rocchetti MT, Centra M, Ranieri E, Gesualdo L. Clin Chem Lab Med; 2008 Feb 15; 46(1):89-99. PubMed ID: 18020972 [Abstract] [Full Text] [Related]
5. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads. Deng B, Dong Z, Liu Y, Wang C, Liu J, Wang C, Qu X. Clin Chim Acta; 2010 Aug 05; 411(15-16):1051-7. PubMed ID: 20361951 [Abstract] [Full Text] [Related]
8. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Novikova SI, He F, Cutrufello NJ, Lidow MS. Neurobiol Dis; 2006 Jul 05; 23(1):61-76. PubMed ID: 16549361 [Abstract] [Full Text] [Related]
11. Sample handling for mass spectrometric proteomic investigations of human urine. Petri AL, Høgdall C, Christensen IJ, Simonsen AH, T'jampens D, Hellmann ML, Kjaer SK, Fung ET, Høgdall E. Proteomics Clin Appl; 2008 Sep 05; 2(9):1184-93. PubMed ID: 21136916 [Abstract] [Full Text] [Related]
12. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients. Xu WH, Chen YD, Hu Y, Yu JK, Wu XG, Jiang TJ, Zheng S, Zhang SZ. J Zhejiang Univ Sci B; 2006 Mar 05; 7(3):235-40. PubMed ID: 16502512 [Abstract] [Full Text] [Related]
13. Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS. Xue A, Gandy RC, Chung L, Baxter RC, Smith RC. Pancreatology; 2012 Mar 05; 12(2):124-9. PubMed ID: 22487522 [Abstract] [Full Text] [Related]
14. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma. Geng X, Wang F, Li YG, Zhu GP, Zhang WM. J Exp Clin Cancer Res; 2007 Dec 05; 26(4):505-8. PubMed ID: 18365545 [Abstract] [Full Text] [Related]
15. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments. Harezlak J, Wang M, Christiani D, Lin X. Bioinformatics; 2007 Sep 15; 23(18):2441-8. PubMed ID: 17626063 [Abstract] [Full Text] [Related]
17. Time course proteomic profile of rat acute myocardial infarction by SELDI-TOF MS analysis. Zhang G, Zhou B, Zheng Y, Feng K, Rao L, Zhang J, Xin J, Zhang B, Zhang L. Int J Cardiol; 2009 Jan 09; 131(2):225-33. PubMed ID: 18180059 [Abstract] [Full Text] [Related]
18. [Detection of differentially expressed proteins in the semen of oligospermia patients by SELDI-TOF-MS technology]. Liu CB, Liang Y, Pan CQ, Zhang J. Zhonghua Nan Ke Xue; 2009 Mar 09; 15(3):232-6. PubMed ID: 19452695 [Abstract] [Full Text] [Related]
19. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides. Penno MA, Ernst M, Hoffmann P. Rapid Commun Mass Spectrom; 2009 Sep 09; 23(17):2656-62. PubMed ID: 19630030 [Abstract] [Full Text] [Related]
20. Pre-analytical factors influencing the stability of cerebrospinal fluid proteins. Simonsen AH, Bahl JM, Danborg PB, Lindstrom V, Larsen SO, Grubb A, Heegaard NH, Waldemar G. J Neurosci Methods; 2013 May 15; 215(2):234-40. PubMed ID: 23537933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]